MQS Management LLC increased its holdings in Cabot Co (NYSE: CBT) during the third quarter, as stated in the most recent filing that the company made with the Securities and Exchange Commission.
The purchase of 6,447 shares in the specialty chemicals company cost the corporation approximately $412,000, which was paid for by the corporation.
Recent months have brought about shifts in the ownership structures of the company on the part of hedge funds and various other types of institutional investors. Raymond James & Associates increased the number of Cabot shares it owned by 8.2% during the year’s first quarter.
As a result of the most recent acquisition of 2,521 additional shares during the fiscal quarter, Raymond James & Associates now owns 33,134 in the specialty chemicals firm.
These shares have a value of $2,267,000 and make up all of Raymond James & Associates’ holdings in the company. Raymond James Financial Services Advisors INC increased the amount of Cabot stock owned by 5.0 percent over the first three months of 2018.
There are now a total of 8,740 shares of the specialty chemicals company’s stock held by Raymond James Financial Services Advisors INC, which have a value of $598,000.
This is because the company purchased 417 additional shares throughout the period in question.
The amount of Cabot stock that AlphaCrest Capital Management LLC owned increased by 13.3% during the first three months of 2018. Following the acquisition of an additional 491 shares during the preceding quarter, AlphaCrest Capital Management LLC now owns 4,176 shares of the specialty chemicals company’s stock, which have a combined value of $286,000 as of the end of the most recent fiscal period. Natixis Advisors L.P.
Added approximately $712 000 in Cabot holdings to its portfolio during the first three months of 2018.
And finally, during the first three months of 2018, Panagora Asset Management INC added a new Cabot investment to its portfolio.
The value of this investment was approximately $282,000 at the time.
The vast majority of the company’s stock is owned by large financial institutions, which account for 94.21% of the total.
When trading on Thursday got underway, the price of CBT was $73.26.
The quick ratio is 1.05, the current ratio is 1.65, and the debt-to-equity ratio is 1.06.
These are the ratios for the three different measures of liquidity.
The company’s stock has a price-to-earnings ratio of 20.35, a beta value of 1.39, and a market value of $4.13 billion at the current time.
The stock price has had a moving average of $71.04 for the past 50 days and a moving average of $71.03 for the past 200 days.
In the past 52 weeks, Cabot Company’s share price has fluctuated between a high of $78.62 and a low of $76.62.
The most recent quarterly results report for Cabot (NYSE: CBT) was released on November 7, a Monday.
In the quarterly report of the specialty chemicals company, the earnings per share came in at $1.55, which was $0.07 more than the average projection of $1.48.
The return on equity for Cabot was 35.30%, and the net margin for the company was 4.84%.
The sales for the company for the quarter came in significantly higher than the predictions of $1.04 billion that the analysts had made, coming in instead at $1.11 billion company; the earnings per share came in at $1.55, which was $0.07 more than the average projection of $1.48.
The return on equity for Cabot was 35.30%, and the net margin for the company was 4.84%.
The sales for the company for the quarter came in significantly higher than the predictions of $1.04 billion that the analysts had made, coming in instead at $1.11 billion.
Analysts who focus on equity research forecast that Cabot Company will make a profit of 6.5 cents per share in 2018.
In addition, the corporation disclosed that it had declared a quarterly dividend, which will be disbursed on March 10. On Friday, February 24, the record shareholders will receive a dividend payment of $0.37 per share. On February 23 of this month, a decision will be made regarding the distribution of this dividend.
This equates to a yield of 2.02% and a dividend payment of $1.48 yearly for each shareholder.
The dividend payout ratio, another name for the DPR, is currently at 41.11% for Cabot.
In recent press releases, several stock research analysts were asked about their thoughts on CBT shares and provided their responses.
In a report distributed on November 16, the investment company Deutsche Bank Aktiengesellschaft raised their price target for Cabot from $80.00 to $90.00 and upgraded the stock from a “hold” rating to a “buy” rating.
The recommendation to “buy” Cabot’s stock from StockNews.com was changed to a “strong-buy” rating on January 28.
Before that date, the recommendation was simply “buy.”
The Cabot Corporation is a leading manufacturer of high-performance materials and specialized chemicals globally. Rubber, carbon blacks of a particular quality, specialty chemicals, fume metal oxides, activated carbons, inkjet colorants, and aerogel are just some products that this company manufactures and sells. Other products include fume metal oxides, activated carbon, and metal oxides.
The company’s three distinct divisions are reinforcement materials, performance chemicals, and purification solutions.
Leave a comment